PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer ; volume:15 ; number:1 ; day:13 ; month:3 ; year:2024 ; pages:1-16 ; date:12.2024
Nature Communications ; 15, Heft 1 (13.3.2024), 1-16, 12.2024
- Creator
-
Lin, Chang-Ching
Chang, Tsung-Cheng
Wang, Yunguan
Guo, Lei
Gao, Yunpeng
Bikorimana, Emmanuel
Lemoff, Andrew
Fang, Yisheng V.
Zhang, He
Zhang, Yanfeng
Ye, Dan
Soria-Bretones, Isabel
Servetto, Alberto
Lee, Kyung-min
Luo, Xuemei
Otto, Joseph J.
Akamatsu, Hiroaki
Napolitano, Fabiana
Mani, Ram
Cescon, David W.
Xu, Lin
Xie, Yang
Mendell, Joshua T.
Hanker, Ariella B.
Arteaga, Carlos L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-46495-2
- URN
-
urn:nbn:de:101:1-2405152131416.404040201036
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Chang-Ching
- Chang, Tsung-Cheng
- Wang, Yunguan
- Guo, Lei
- Gao, Yunpeng
- Bikorimana, Emmanuel
- Lemoff, Andrew
- Fang, Yisheng V.
- Zhang, He
- Zhang, Yanfeng
- Ye, Dan
- Soria-Bretones, Isabel
- Servetto, Alberto
- Lee, Kyung-min
- Luo, Xuemei
- Otto, Joseph J.
- Akamatsu, Hiroaki
- Napolitano, Fabiana
- Mani, Ram
- Cescon, David W.
- Xu, Lin
- Xie, Yang
- Mendell, Joshua T.
- Hanker, Ariella B.
- Arteaga, Carlos L.
- SpringerLink (Online service)